Home Medicine Technical and clinical evaluation of the VITROS® Immunodiagnostic Products 25-OH Vitamin D Total Assay – comparison with marketed automated immunoassays and a liquid chromatography-tandem mass spectrometry method
Article
Licensed
Unlicensed Requires Authentication

Technical and clinical evaluation of the VITROS® Immunodiagnostic Products 25-OH Vitamin D Total Assay – comparison with marketed automated immunoassays and a liquid chromatography-tandem mass spectrometry method

  • EMAIL logo , , , , and
Published/Copyright: June 4, 2013

Abstract

Background: The study was conducted to evaluate the technical and clinical performance of the VITROS® Immunodiagnostic Products 25-OH Vitamin D Total Assay, and compare it with the performance of five marketed automated assays and a liquid chromatography/mass spectrometry reference method (LC-MS/MS).

Methods: Three hundred patient serum samples were used to compare the correlation of the VITROS® 25-OH Vitamin D Total Assay with both the other immunoassays and the LC-MS/MS method, using Passing-Bablok regression and Bland-Altman analyses. Concordance of the diagnosis of vitamin D status was calculated to test the agreement between the different assays. In addition, samples containing vitamin D2 were used to test the assay’s ability to detect the D2 form of the vitamin.

Results and conclusions: These results from the VITROS® 25-OH Vitamin D Total Assay generally correlated well with those from most of the marketed immunoassays. Cross-reactivity of the D2 form was calculated as being close to 100%. Additionally, we found substantial variability in performance amongst the various assays, which suggests the need for optimisation and recalibration of commercial methods.


Corresponding author: Dr. Etienne Cavalier, Department of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Domaine du Sart-Tilman, Liège, Belgium, E-mail:

The authors thank Ortho Clinical Diagnostics for their financial sponsorship of this study.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in thestudy design; in the collection, analysis, and interpretationof data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future [minireview]. Exp Biol Med 2010;235:1034–5.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000281917900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1258/ebm.2010.010014Search in Google Scholar PubMed

2. Rosen CJ. Clinical practice: vitamin D insufficiency. N Engl J Med 2011;364:248–54.10.1056/NEJMcp1009570Search in Google Scholar PubMed

3. Pitz S, Tomaschitz A, März W, Dreschler C, Ritz E, Zittermann A, et al. Vitamin D: cardiovascular disease and mortality (review). Clin Endocrinol 2011;75:575–84.10.1111/j.1365-2265.2011.04147.xSearch in Google Scholar PubMed

4. Holick MF. Vitamin D: its role in cancer prevention and treatment (review). Prog Biophys Mol Biol 2006;92:49–59.10.1016/j.pbiomolbio.2006.02.014Search in Google Scholar PubMed

5. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: the aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137–42.10.1136/ard.2007.069831http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000248690600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed PubMed Central

6. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69:1155–7.10.1136/ard.2009.120329http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000278017700038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

7. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8–28.10.1152/ajprenal.00336.2004Search in Google Scholar PubMed

8. Heaney BP. Vitamin D: how much do we need and how much is too much? Osteoporosis Int 2000;11:553–5.10.1007/s001980070074Search in Google Scholar PubMed

9. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008;93:677–81.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000253822700006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1210/jc.2007-2308Search in Google Scholar PubMed PubMed Central

10. Farrell C-J, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012;58:531–42.10.1373/clinchem.2011.172155Search in Google Scholar PubMed

11. Le Goff C, Peeters S, Crine Y, Luks P, Souberbielle JC, Cavalier E. Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clin Chem Lab Med 2012;50:2031–2.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000310695300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1515/cclm-2012-0164Search in Google Scholar PubMed

12. Cavalier E, Wallace AM, Carlisi A, Chapelle JP, Delanaye P, Souberbielle JC. Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clin Chem Lab Med 2011;49:555–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000288238500029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1515/CCLM.2011.072Search in Google Scholar PubMed

13. Thienpont LM, Stepman HC, Vesper HW. Standardization of measurements of 25-Hydroxyvitamin D3 and D2. Scand J Clin Lab Invest 2012;72:41–9.Search in Google Scholar

14. Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest 2012;72:32–40.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000303248300006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

Received: 2012-02-21
Accepted: 2013-05-13
Published Online: 2013-06-04
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Letters to the Editor
  2. Effect of hemoglobin Porto Alegre on glycated hemoglobin (HbA1c) measurement with the HA-8160 high performance liquid chromatography method
  3. Influence of sample type and delayed separation from cells on the measurement of B-type natriuretic peptide with the Architect system
  4. Efficient use of basic biochemical methods to prove the presence of monoclonal protein in the clinical diagnosis of malignant monoclonal gammopathy
  5. Ammonia does not interfere with the Diazyme adenosine deaminase test
  6. Interindividual variability of hemolysis in plasma samples during pneumatic tube system transport
  7. Kidney stones in a southeast European population from Bulgaria
  8. The influence of non-specificity of the creatinine assay on eGFR
  9. Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy
  10. Congress Abstracts
  11. Congress of Clinical Chemistry and Laboratory Medicine / 10th Annual Meeting of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Dresden, Germany, 23rd–26th October, 2013*)
  12. Masthead
  13. Masthead
  14. Editorials
  15. Stabilization of glucose in blood samples: out with the old, in with the new
  16. Component-resolved diagnostics: laboratory results are not enough
  17. Reviews
  18. Molecular basis and clonal evolution of myeloproliferative neoplasms
  19. Current and future use of “dried blood spot” analyses in clinical chemistry
  20. Opinion Papers
  21. Staging chronic kidney disease and estimating glomerular filtration rate: an opinion paper about the new international recommendations
  22. Age, stage and biomarkers for the definition of CKD: a construction in progress
  23. Guidelines and Recommendations
  24. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review
  25. General Clinical Chemistry and Laboratory Medicine
  26. Citric/citrate buffer: an effective antiglycolytic agent
  27. Relationship between coffee consumption, oxidant status, and antioxidant potential in the Japanese general population
  28. Investigation of apparent non-albuminuric proteinuria in a primary care population
  29. Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
  30. Technical and clinical evaluation of the VITROS® Immunodiagnostic Products 25-OH Vitamin D Total Assay – comparison with marketed automated immunoassays and a liquid chromatography-tandem mass spectrometry method
  31. Isolated IgE reactivity to native walnut vicilin-like protein (nJug r 2) on ISAC™ microarray is due to cross-reactive carbohydrate epitopes
  32. Reference Values and Biological Variations
  33. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase
  34. IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children
  35. Cardiovascular Diseases
  36. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
  37. Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test
  38. A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery
  39. Diabetes
  40. External quality assessment of HbA1c and its effect on comparison between Swedish pediatric diabetes clinics. Experiences from the Swedish pediatric diabetes quality register (Swediabkids) and Equalis
  41. Infectious Diseases
  42. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis
  43. Errata
  44. Recommendations for clinical laboratory science reports regarding properties, units, and symbols: the NPU format
  45. Standardization and analytical goals for glycated hemoglobin measurement
Downloaded on 21.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0138/html
Scroll to top button